- +1 858 909 0079
- +1 858 909 0057
- [email protected]
- +1 858 909 0079
- [email protected]
Cat# | Product Name | Swiss Prot# | Size | Price (US$) | Order |
PP0588 | Recombinant Protein-Mycobacterium tuberculosis 10 kDa chaperonin-Protein (a.a.1 to 100) | P09621 | 100 µg | 1195 | |
PP0589 | Recombinant Protein-Mycobacterium tuberculosis 6 kDa early secretory antigenic target ESAT-6 (a.a.19 to 95) | P0A564 | 100 µg | 1195 | |
PP0590 | Recombinant Protein-Mycobacterium tuberculosis 45-47 kDa antigen (a.a.39 to 325) | Q50906 | 100 µg | 1195 | |
PP0591 | Recombinant Protein-Mycobacterium tuberculosis ahpD (a.a.21 to 177) | P0A5N4 | 100 µg | 1195 | |
PP0592 | Recombinant Protein-Mycobacterium tuberculosis AhpC (a.a.33 to 195) | Q7BHK8 | 100 µg | 1195 | |
PP0593 | Recombinant Protein-Mycobacterium tuberculosis Antigen MTB48 (a.a.61 to 460) | Q933K8 | 100 µg | 1195 | |
PP0594 | Recombinant Protein-Mycobacterium tuberculosis Catalase-peroxidase (a.a.61 to 460) | Q08129 | 100 µg | 1195 | |
PP0595 | Recombinant Protein-Mycobacterium tuberculosis Cell surface lipoprotein MPT83 p23 (a.a.38 to 220) | P0A670 | 100 µg | 1195 | |
PP0596 | Recombinant Protein-Mycobacterium tuberculosis 2-oxoglutarate dehydrogenase E2 (a.a.61 to 553) | P65633 | 100 µg | 1195 | |
PP0597 | Recombinant Protein-Mycobacterium tuberculosis reductase (a.a.28 to 269) | P0A5Y6 | 100 µg | 1195 | |
PP0598 | Recombinant Protein-Mycobacterium tuberculosis Secreted antigenic protein MTSA-10 (a.a.14 to 100) | P0A566 | 100 µg | 1195 | |
PP0599 | Recombinant Protein-Mycobacterium tuberculosis ESAT-6 esxI Antigen Mtb9.9B (a.a.21 to 94) | P96364 | 100 µg | 1195 | |
PP0600 | Recombinant Protein-Mycobacterium tuberculosis Lipoprotein antigen 22 kDa (a.a.45 to 154) | Q8VJV1 | 100 µg | 1195 | |
PP0601 | Recombinant Protein-Mycobacterium tuberculosis Rv0092 antigen (a.a.21 to 98) | B8YDF2 | 100 µg | 1195 | |
PP0602 | Recombinant Protein-Mycobacterium tuberculosis C antigen cfp2 (a.a.30 to 185) | A2VKA2 | 100 µg | 1195 | |
PP0603 | Recombinant Protein-Mycobacterium tuberculosis C protein antigen 6 cfp6 (a.a.23 to 98) | A2VLX4 | 100 µg | 1195 | |
PP0604 | Recombinant Protein-Mycobacterium tuberculosis C T-cell antigen TB8.4 (a.a.34 to 110) | A2VH80 | 100 µg | 1195 | |
PP0605 | Recombinant Protein-Mycobacterium tuberculosis C Secreted antigen 85-A fbpA (a.a.59 to 363) | A2VMI3 | 100 µg | 1195 | |
PP0606 | Recombinant Protein-Mycobacterium tuberculosis C Secreted antigen 85-B fbpB (a.a.40 to 325) | A2VJ01 | 100 µg | 1195 | |
PP0607 | Recombinant Protein-Mycobacterium tuberculosis C Mpb51 antigen protein FbpD (a.a.38 to 310) | A2VMI2 | 100 µg | 1195 | |
PP0608 | Recombinant Protein-Mycobacterium tuberculosis antigen pra (a.a.34 to 158) | A4KG13 | 100 µg | 1195 | |
PP0609 | Recombinant Protein-Mycobacterium tuberculosis Secreted antigen 85-A fbpA (a.a.42 to 338) | A4KMS1 | 100 µg | 1195 | |
RPP0588 | cDNA-Mycobacterium tuberculosis 10 kDa chaperonin-Protein (a.a.1 to 100) | P09621 | 2 µg | 800 | |
RPP0589 | cDNA-Mycobacterium tuberculosis 6 kDa early secretory antigenic target ESAT-6 (a.a.19 to 95) | P0A564 | 2 µg | 800 | |
RPP0590 | cDNA-Mycobacterium tuberculosis 45-47 kDa antigen (a.a.39 to 325) | Q50906 | 2 µg | 1430 | |
RPP0591 | cDNA-Mycobacterium tuberculosis ahpD (a.a.21 to 177) | P0A5N4 | 2 µg | 780 | |
RPP0592 | cDNA-Mycobacterium tuberculosis AhpC (a.a.33 to 195) | Q7BHK8 | 2 µg | 810 | |
RPP0593 | cDNA-Mycobacterium tuberculosis Antigen MTB48 (a.a.61 to 460) | Q933K8 | 2 µg | 1995 | |
RPP0594 | cDNA-Mycobacterium tuberculosis Catalase-peroxidase (a.a.61 to 460) | Q08129 | 2 µg | 1995 | |
RPP0595 | cDNA-Mycobacterium tuberculosis Cell surface lipoprotein MPT83 p23 (a.a.38 to 220) | P0A670 | 2 µg | 910 | |
RPP0596 | cDNA-Mycobacterium tuberculosis 2-oxoglutarate dehydrogenase E2 (a.a.61 to 553) | P65633 | 2 µg | 2460 | |
RPP0597 | cDNA-Mycobacterium tuberculosis reductase (a.a.28 to 269) | P0A5Y6 | 2 µg | 1205 | |
RPP0598 | cDNA-Mycobacterium tuberculosis Secreted antigenic protein MTSA-10 (a.a.14 to 100) | P0A566 | 2 µg | 800 | |
RPP0599 | cDNA-Mycobacterium tuberculosis ESAT-6 esxI Antigen Mtb9.9B (a.a.21 to 94) | P96364 | 2 µg | 800 | |
RPP0600 | cDNA-Mycobacterium tuberculosis Lipoprotein antigen 22 kDa (a.a.45 to 154) | Q8VJV1 | 2 µg | 800 | |
RPP0601 | cDNA-Mycobacterium tuberculosis Rv0092 antigen (a.a.21 to 98) | B8YDF2 | 2 µg | 800 | |
RPP0602 | cDNA-Mycobacterium tuberculosis C antigen cfp2 (a.a.30 to 185) | A2VKA2 | 2 µg | 775 | |
RPP0603 | cDNA-Mycobacterium tuberculosis C protein antigen 6 cfp6 (a.a.23 to 98) | A2VLX4 | 2 µg | 800 | |
RPP0604 | cDNA-Mycobacterium tuberculosis C T-cell antigen TB8.4 (a.a.34 to 110) | A2VH80 | 2 µg | 800 | |
RPP0605 | cDNA-Mycobacterium tuberculosis C Secreted antigen 85-A fbpA (a.a.59 to 363) | A2VMI3 | 2 µg | 1520 | |
RPP0606 | cDNA-Mycobacterium tuberculosis C Secreted antigen 85-B fbpB (a.a.40 to 325) | A2VJ01 | 2 µg | 1425 | |
RPP0607 | cDNA-Mycobacterium tuberculosis C Mpb51 antigen protein FbpD (a.a.38 to 310) | A2VMI2 | 2 µg | 1360 | |
RPP0608 | cDNA-Mycobacterium tuberculosis antigen pra (a.a.34 to 158) | A4KG13 | 2 µg | 620 | |
RPP0609 | cDNA-Mycobacterium tuberculosis Secreted antigen 85-A fbpA (a.a.42 to 338) | A4KMS1 | 2 µg | 1480 |
Mycobacterium tuberculosis cDNA and recombinant antigen
Mycobacterium tuberculosis is the causative agent of tuberculosis (TB), a serious infectious disease that affects millions of people worldwide. The bacterium possesses various antigens that play important roles in its pathogenesis and immune response. Let’s explore some of these antigens:
10 kDa chaperonin-protein: Also known as the heat shock protein 10 (Hsp10), this antigen is a chaperonin that is involved in protein folding and stress response. It has been shown to interact with the host immune system and modulate the immune response during M. tuberculosis infection.
45-47 kDa antigen: This antigen is a cell wall-associated protein of M. tuberculosis that is recognized by the host immune system during infection. It has been shown to elicit strong immune responses and is often used in diagnostic tests for TB.
AhpD and AhpC: AhpD and AhpC are two antioxidant enzymes of M. tuberculosis that are involved in protecting the bacterium from oxidative stress. They play a role in the ability of M. tuberculosis to survive and persist in the host immune response.
Antigen MTB48: Antigen MTB48 is a secreted protein of M. tuberculosis that is involved in the host-pathogen interaction. It has been shown to stimulate immune responses in infected individuals and is considered to be an important antigen in the context of TB.
Catalase-peroxidase: Catalase-peroxidase is an enzyme of M. tuberculosis that is involved in protecting the bacterium from oxidative damage. It has been shown to play a role in the virulence of M. tuberculosis by modulating the host immune response.
Cell surface lipoprotein MPT83 p23: MPT83 p23 is a cell surface lipoprotein of M. tuberculosis that is involved in the immune response during TB infection. It has been shown to stimulate immune responses and is considered to be an important antigen in the context of TB.
These are just a few examples of the many antigens present in Mycobacterium tuberculosis. These antigens play crucial roles in the pathogenesis and immune response of tuberculosis, including evasion of the host immune system, persistence in the host, and modulation of the immune response.
The use of recombinant proteins/cDNA in academic research and therapeutic applications has skyrocketed. However, in heterologous expression systems, successful recombinant protein expression is dependent on a variety of factors, including codon preference, RNA secondary structure, and GC content. When compared to pre-optimization, more and more experimental results demonstrated that the expression level was dramatically increased, ranging from two to hundred times depending on the gene. Bioclone has created a proprietary technology platform that has resulted in the creation of over 6,000 artificially synthesized codon-optimized cDNA clones (cloned in E. coli expression Vector), which are ready for production of the recombinant proteins.
Mycobacterium tuberculosis cDNA and recombinant antigens are commonly used in diagnosis, vaccine development, and drug discovery. Diagnostic applications include PCR-based assays to detect the presence of M. tuberculosis in clinical samples, such as sputum and other bodily fluids. The recombinant antigens can also be used in ELISA and lateral flow immunoassay formats to detect the presence of antibodies against M. tuberculosis in patient samples. Additionally, recombinant antigens can be used to detect the presence of M. tuberculosis-specific T cells in patient samples.
Vaccine development applications include the use of M. tuberculosis cDNA and recombinant antigens to develop new vaccines against the disease. This includes the development of subunit vaccines and DNA vaccines, which are composed of M. tuberculosis cDNA and recombinant antigens.
Drug discovery applications include the use of M. tuberculosis cDNA and recombinant antigens to identify novel drug targets and to develop new molecules that can inhibit the growth of M. tuberculosis. Additionally, M. tuberculosis cDNA and recombinant antigens can be used to perform high-throughput screenings to identify novel molecules that can inhibit the growth of M. tuberculosis.
Get the Latest News and Updates by Email
6393 Nancy Ridge Dr. Suite A
San Diego, CA 92121 USA
Fax: +1-858-909-0057
Get the Latest News and Updates by Email
© 2023 Bioclone Inc. All Rights Reserved.
Magnetic Beads Make Things Simple